GRAIL (MEX:GRAL) Current Accrued Expense: MXN1,125 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MEX:GRAL GRAIL Inc MEX:GRAL
13 GF Score
Price MXN1,325.00
! 2 Warning Signs
View Full Analysis

What is GRAIL Current Accrued Expense?

GRAIL MEX:GRAL 13 Current Accrued Expense is MXN1,125 Mil as of Jun. 2026. GuruFocus rates MEX:GRAL with a GF Score™ of 13/100. The stock has 2 warning signs investors should review.

GRAIL's Current Accrued Expense for the quarter that ended in Jun. 2026 was MXN1,125 Mil.

GRAIL's quarterly Current Accrued Expense increased from Dec. 2025 (MXN498 Mil) to Mar. 2026 (MXN1,051 Mil) and increased from Mar. 2026 (MXN1,051 Mil) to Jun. 2026 (MXN1,125 Mil).

GRAIL's annual Current Accrued Expense declined from Dec. 2023 (MXN549 Mil) to Dec. 2024 (MXN474 Mil) but then increased from Dec. 2024 (MXN474 Mil) to Dec. 2025 (MXN498 Mil).

GRAIL Current Accrued Expense Historical Data

* Premium members only.

The historical data trend for GRAIL's Current Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

GRAIL Current Accrued Expense Chart

GRAIL Annual Data
Trend Dec18 Dec19 Dec22 Dec23 Dec24 Dec25
Current Accrued Expense
Get a 7-Day Free Trial 314.87 524.62 548.64 473.65 497.79

GRAIL Quarterly Data
Dec18 Dec19 Jun20 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Current Accrued Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 498.13 493.55 497.79 1,050.71 1,125.37
MEX:GRAL
13GF Score
GRAIL Inc MEX:GRAL
Current Accrued Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

GRAIL Current Accrued Expense Calculation

Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.

What does a Current Accrued Expense of MXN1,125 Mil mean?
GRAIL (MEX:GRAL) has a Current Accrued Expense of MXN1,125 Mil as of Jun. 2026. Current Accrued Expense records the total amount of accrued expenses. View historical data on GRAIL and its competitors.
Is GRAIL's Current Accrued Expense too high?
GRAIL's current Current Accrued Expense is MXN1,125 Mil. Overall, GRAIL has a GF Score™ of 13/100, reflecting its overall financial health beyond just this single metric.
How does GRAIL's Current Accrued Expense compare to VCYT and ADPT?
GRAIL's Current Accrued Expense of MXN1,125 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Accrued Expense for a Medical Diagnostics & Research company?
A good Current Accrued Expense depends on the Medical Diagnostics & Research industry context. However, Current Accrued Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Accrued Expense mean?
A high Current Accrued Expense can signal that a stock is expensive relative to its fundamentals. Current Accrued Expense records the total amount of accrued expenses. View historical data on GRAIL and its competitors. GRAIL's current Current Accrued Expense is MXN1,125 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is GRAIL stock overvalued right now?
GRAIL (MEX:GRAL) has a current Current Accrued Expense of MXN1,125 Mil. The current Current Accrued Expense is MXN1,125 Mil. GRAIL's overall GF Score™ is 13/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Accrued Expense calculated?
Current Accrued Expense is calculated from a company's financial statements. For GRAIL (MEX:GRAL), the current Current Accrued Expense is MXN1,125 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

GRAIL Business Description

Other Exchanges GRAL:USANL0:Germany
Address 1525 O’Brien Drive, Menlo Park, CA, USA, 94025
GRAIL Inc is a healthcare company focused on developing technologies for early cancer detection. The company has developed a multi-cancer early detection blood test that has the ability to detect all types of cancer, across all stages. It operates in one reportable operating segment which provides multi-cancer early detection testing and service.
13GF Score

Get the complete analysis for MEX:GRAL

Current Accrued Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN1,325.00
Price